|
February 23, 2018 Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 1:33 Access Vascular receives FDA clearance for its HydroPICC Catheterhttps://www.prnewswire.com/news-releases/access-vascular-receives-fda-clearance-for-its-hydropicc-catheter-300602448.html 3:30 Sanofi’s FDA-approved yellow fever vaccine returning to the US http://www.precisionvaccinations.com/yf-vax-yellow-fever-vaccine-scheduled-usa-availability-late-2018 https://wwwnc.cdc.gov/travel/news-announcements/yellow-fever-vaccine-access https://www.cdc.gov/mmwr/volumes/66/wr/mm6617e2.htm 5:30 MabSpace Biosciences announces FDA approval of IND for MSB2311, a second generation PD-L1 antibody with pH dependent antigen binding and recycling property https://www.businesswire.com/news/home/20180222005053/en/MabSpace-Biosciences-Announces-FDA-Approval-IND-MSB2311 6:57 FDA reduces regulations, approves record number of new generics http://www.washingtonexaminer.com/fda-reduces-regulations-approves-record-number-of-new-generics/article/2649698 http://nascentmc.com Here is more info about us. Our US-based company, Nascent Medical, LLC, has a team of over 100 PhD-/MD-level writers who can write about any medical, scientific or technical topic. Have you updated your blog or posted any press releases lately? That's a small project that some clients like to test us out with to start. |